Pfizer tests new medicine in healthy volunteers for first time
NCT ID NCT06965465
Summary
This is Pfizer's first human study of a new medicine called PF-07999415. It aims to check if a single injection is safe and how the body processes it in 32 healthy adults aged 18-65. Participants stay in a medical facility for 2 weeks after their injection for close monitoring, then return for follow-up visits over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - Brussels
Brussels, Bruxelles-capitale, Région de, B-1070, Belgium
Conditions
Explore the condition pages connected to this study.